Origins


 

Discovery

PuraMatrix™ technology was discovered and carefully engineered more than 15 years ago at the Massachusetts Institute of Technology, forming the basis for a family of unique and proprietary biomaterials – self-assembling nanofiber scaffolds (SANS). This technology and its applications, covered today by multiple patents, was developed through the work of an extraordinary group of scientific founders who continue to support the efforts of Gentaur.

 

Intellectual Property

Gentaur holds an extensive portfolio of owned and licensed patents that assure exclusive rights and protection of PuraMatrix™ and of its applications. The portfolio consists of domestic and foreign patents across an entire family of self-assembling peptide biomaterials and peptide sequences. These patents include composition of matter claims, method claims, product by process claims and kit claims. In addition to the company’s own intellectual property, many of the granted patents are owned by the Massachusetts Institute of Technology and exclusively licensed worldwide to Gentaur.